RE:RE:RE:RE:Just going to leave this hereThey are doing alright considering loss of sales for Q3 due to COVID. Also some bad luck with a vendor and took a loss. They did get contracts and they only started commercialization 2H 2020. They need to cool it with the patents and spend more on sales. It's a good sign if consultants accept shares as payment. Wait and see what the raise is going to be like. Issued and outstanding is about 170 million now. I like the company;p